Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Male breast cancer
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2020) 98 (7): 487–492.
Published Online: 28 April 2020
...Joanna Huszno; Zofia Kołosza; Jolanta Mrochem-Kwarciak; Aleksander Zajusz Background: The aim of the present study was to assess the blood neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) as prognostic factors in male breast cancer (BC...
Journal Articles
Subject Area:
Oncology
Tal Grenader, Rinat Yerushalmi, Margarita Tokar, Georgeta Fried, Bella Kaufman, Tamar Peretz, David B. Geffen
Journal:
Oncology
Oncology (2014) 87 (1): 1–6.
Published Online: 20 June 2014
... and the potential benefit of adjuvant chemotherapy. The primary aim of this study was to assess RS distribution in Israeli male breast cancer (MBC) patients. Methods: The study population included 65 newly diagnosed Israeli MBC patients. Clinical and pathologic data were collected at the time of referral...
Journal Articles
Subject Area:
Oncology
Alfonso Sánchez-Muñoz, Alicia Román-Jobacho, Lidia Pérez-Villa, Pedro Sánchez-Rovira, José Miramón, Diego Pérez, Maria-Isabel Sáez, Vanesa de Luque, Laura Medina, César Luis Ramírez-Tortosa, Luis Vicioso, José Antonio Medina, Nuria Ribelles, Emilio Alba
Journal:
Oncology
Oncology (2012) 83 (4): 228–233.
Published Online: 16 August 2012
... the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. Methods: A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen receptor (ER), progesterone...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (1985) 42 (6): 345–349.
Published Online: 17 June 2009
... to in the content or advertisements. Male breast cancer Hormone therapy Oncology 42: 345-349 (1985) (g) 1985 S. K arger AG. Basel 0030-2414/85/0426-0345 $ 2.75/0 Hormonal Treatment of Disseminated Male Breast Cancer Massimo Lopez, Luigi Di Lauro, Bonaventura Lazzaro, Paola Papaldo Department of Medical...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (1985) 42 (4): 205–209.
Published Online: 17 June 2009
...% response rate was observed. Our data suggest that cancer of the breast in the male is responsive to the same combinations used in the female, with regimens including adriamycin being probably superior to regimens without it. 17 6 2009 Male breast cancer Chemotherapy © 1985 S. Karger AG...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (1974) 29 (3): 181–189.
Published Online: 09 June 2009
...N. Walach; A. Hochman 42 cases of male breast cancer were studied. The disease is diagnosed in males at a later stage than in females. The prognosis of this disease in males is more favorable than in females: in stage I there is an 83% 5-year survival, while in stage II there is 62% 5-year survival...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (1976) 33 (4): 188–191.
Published Online: 09 June 2009
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Male breast cancer Calusterone...
